Ovarian Cancer Prevention Clinical Trial
Official title:
Opportunistic Salpingectomy in Non-gynecological Surgeries - a Pilot Study
Verified date | September 2023 |
Source | Meir Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this study is to evaluate patient's compliance for opportunistic salpingectomy (OS) and procedure feasibility in non gynecological abdominal surgeries
Status | Completed |
Enrollment | 42 |
Est. completion date | February 28, 2023 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 40 Years and older |
Eligibility | Inclusion Criteria: - Women who were candidates for non-gynecological abdominal surgery - Aged 45 or older, or aged 40 or older with a desire for bilateral salpingectomy Exclusion Criteria: - Pregnant women - Candidates for urgent surgery |
Country | Name | City | State |
---|---|---|---|
Israel | Meir medical center | Kfar Saba |
Lead Sponsor | Collaborator |
---|---|
Dana Josephy |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | patients willing for salpingectomy | The number of patients that will agree for salpingectomy | day of enrollment | |
Primary | patients undergoing salpingectomy | The number of patients that will undergo salpingectomy | from enrollment and up to 6 weeks | |
Primary | length of salpingectomy | the length (in minutes) of salpingectomy | within surgery | |
Primary | surgical complications | complications during or after salpingectomy | up to 30 days from surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03480776 -
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
|
Phase 2 |